Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAPNmAb005, an anti‐tau antibody targeting synaptic tau oligomers, in Phase 1 for treatment of Alzheimer's Disease and primary tauopathies.AuthorsTai, Chin‐Yin; Ma, Haou‐Tzong; Li, Chung‐Lin; Fang Wu, Meng‐; Wang, Silas; Wu, Chia‐Lin; Lai, Yen‐Ting; Serrano, Geidy E; Beach, Thomas G; Margolin, Richard A; Zhang, Lili; Jang, Ming‐Kuei; Navia, BradfordPublicationAlzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, Vol 19, Issue 21, p1ISSN1552-5260Publication typeArticleDOI10.1002/alz.076888